Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024

CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Chris Taylor ,Dan Budwick ,Nasdaq ,Agios Pharmaceuticals Inc ,Corporate Communications ,Health Care Conference On ,Agios Pharmaceuticals ,Annual Health Care Conference ,Investor Relations ,Region ,